Evaluation of the xerostomia, taste and smell impairments after Covid-19

Med Oral Patol Oral Cir Bucal. 2021 Sep 1;26(5):e568-e575. doi: 10.4317/medoral.24510.

Abstract

Background: The purpose of this study was to explore the effects of coronavirus disease 19 (Covid-19) on the oral cavity by evaluating the oral findings in the patients who recovered after treatment.

Material and methods: This study involved confirmed Covid-19 patients whose treatment completed at least two weeks ago. A questionnaire consist of eight parts was applied to explore the oral findings after Covid-19. Also stimulated salivary flow rate was evaluated with a salivary flow test.

Results: 177 patients reached and 107 of them participate in the study. Regarding gender significant differences were found in terms of the presence of taste impairment after treatment (p=0.007), the degree of taste (p=0.021) and smell (p=0.010) impairment. 18 % (5/27) of the patients evaluated were showed hyposalivation. No significant differences were observed regarding salivary flow between males (mean±SD: 1.14±0.65) and females (mean±SD: 1.12±0.43), (p=0.928); among the patients having treatment at home (mean±SD: 1.03±0.48) or hospital (mean±SD: 1.33±0.65), (p=0.187). In some of the patients' taste [15], smell [23] impairment, and xerostomia [43] still observed at least two weeks after the treatment is completed.

Conclusions: The most frequent finding in patients after the treatment was xerostomia. Taste and smell impairments were more frequently observed in females.

MeSH terms

  • COVID-19*
  • Female
  • Humans
  • Male
  • SARS-CoV-2
  • Smell
  • Taste
  • Taste Disorders / diagnosis
  • Taste Disorders / etiology
  • Xerostomia* / diagnosis
  • Xerostomia* / etiology